Abstract
We have investigated the influence of the intracellular free radical donors hydroxylamine (giving nitric oxide [NO]) and tert-butylhydroperoxide (giving hydroperoxide [“H2O2”]) on glucose- and cyclic adenosine monophosphate (cAMP)-induced transduction signaling in islet hormone release. Both donors dose dependently inhibited glucose-stimulated insulin release and induced modest (hydroxylamine) or profound (tert-butylhydroperoxide) suppression of 45Ca2+-efflux from perifused islets. By contrast, both donors stimulated glucagon release. Similar effects on hormone release were displayed after K+-depolarization. Insulin and glucagon release stimulated by activation of the cAMP system through isobutylmethylxanthine (IBMX) at basal glucose was modestly potentiated by low concentrations of both donors. These effects were still observed, although less pronounced, in K+-depolarized islets. In vitro as well as in vivo, the NO-synthase inhibitor NG-nitro-L-arginine methyl ester inhibited IBMX-induced glucagon release, but did not affect insulin release. The results suggest that NO and hydroperoxide inhibit glucose-stimulated insulin release by perturbing Ca2+ fluxes and probably acting through S-nitrosylation (NO) or oxidation (hydroperoxide) of thiol groups critical to the secretory process. These effects are largely independent of depolarization events. By contrast, both NO and hydroperoxide can potentiate cAMP-stimulated hormone release presumably at a distal site in the stimulus-secretion coupling.
Similar content being viewed by others
References
Moncada, S., Palmer, R. M. J., and Higgs, E. A. (1991). Pharmacol. Rev. 43, 109–142.
Kerwin, J. F. and Heller, M. (1994). Med. Res. Rev. 14, 23–74.
Panagiotidis, G., Alm, P., and Lundquist, I. (1992). Eur. J. Pharmacol. 229, 277–278.
Schmidt, H. H. H. W., Warner, T. D., Ishii, K., Sheng, H., and Murad, F. (1992). Science 255, 721–723.
Corbett, J. A., Wang, J. L., Misko, T. P., Zhao, W., Hickey, W. F., and McDaniel, M. L. (1993). Autoimmunity 15, 145–153.
Panagiotidis, G., Åkesson, B., Alm, P., and Lundquist, I. (1995). Endocrine 2, 787–792.
Panagiotidis, G., Åkesson, B., Rydell, E., and Lundquist, I. (1995). Br. J. Pharmacol. 114, 289–296.
Åkesson, B. and Lundquist, I. (1996). Diabetes Res. 31, 91–99.
Åkesson, B., Mosén, H., Panagiotidis, G., and Lundquist, I. (1996). Br. J. Pharmacol. 119, 758–764.
Salehi, A., Carlberg, M., Henningsson, R., and Lundquist I. (1996). Am. J. Physiol. 270 (Cell Physiol. 39), C1634-C1641.
Henningsson, R. and Lundquist, I. (1998). Am. J. Physiol. 275 (Endocrinol. Metab. 38), E500-E506.
Salehi, A., Parandeh, F., and Lundquist, I. (1998). Cell. Signal. 10, 645–651.
Salehi, A., Parandeh, F., and Lundquist, I. (1998). Biosci. Rep. 18, 19–28.
Åkesson, B. and Lundquist, I. (1998). Biosci. Rep. 18, 199–213.
Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., and Loscalzo, J. (1992). Proc. Natl. Acad. Sci. USA 89, 444–448.
Lundquist, I., Panagiotidis, G., and Stenström, A. (1991). Pancreas 6, 522–527.
Panagiotidis, G., Stenström, A., and Lundquist, I. (1993). Eur. J. Pharmacol. 233, 285–290.
Panagiotidis, G., Stenström, A., and Lundquist, I. (1994). Endocrine 2, 571–576.
Panagiotidis, G., Lindström, P., Stenström, A., and Lundquist, I. (1994). Metabolism 42, 1398–1404.
Salehi, A., Chen, D., Håkanson, R., Nordin, G., and Lundquist, I. (1999). J. Physiol. 514, 579–591.
Ekholm, R., Ericson, L. E., and Lundquist, I. (1971). Diabetologia 7, 339–348.
Ericson, L. E., Håkanson, R., and Lundquist, I. (1977). Diabetologia 13, 117–124.
Stenström, A. and Lundquist, I. (1990). Biogenic Amines 7, 547–555.
Demaster, E. G., Rau, L., Archer, S. L., and Weir, E. K. (1989). Biochem. Biophys. Res. Commun. 163, 527–533.
Southan, E., and Garthwaite, J. (1991). Neurosci. Lett. 130, 107–111.
Cunningham, J. M., Mabley, J. G., Delaney, C. A., and Green, I. C. (1994). Mol. Cell. Endocrinol. 102, 23–29.
Orrenius, S. and Moldéus, P. (1984) Trends Pharm. Sci. 5, 432–435.
Tsuura, Y., Ishida, H., Hayashi, S., Sakamoto, K., horie, M., and Seino, Y. (1994). J. Gen. Physiol. 104, 1079–1098.
Antoine, M.-H., Oudraogo, R., Sergooris, J., Hermann, M., Herchuelz, A., and Lebrun, P. (1996). Eur. J. Pharmacol. 313, 229–35.
Hellman, B., Idahl, L.-Å, Lernmark, Å., Sehlin, J., and Täljedahl, I-B. (1974). Exerpt Med. Int. Congr. Ser. 312, 65–78.
Ammon, H. P. T., and Mark, M. (1985). Cell Biochem. Funct. 3, 157–171.
Krippeit-Drews, P., Krämer, C., Welker, S., Lang, F., Ammon, H. P. T., and Drews, G. (1999). J. Physiol. 512, 471–481.
Ammon, H. P. T., Akhtar, M. S., Niklas, H. (1977). Mol. Pharmacol. 13, 598–605.
Ammon, H. P. T., Akhtar, M. S., Grimm, A., and Niklas, H. (1979). Nan-Schmied. Arch. Pharmacol. 307, 91–96.
Meffert, M. K., Calakos, N. C., Scheller, R. H., and Schulman, H. (1996). Neuron 16, 1229–1236.
Creutz, C. E. (1981). J. Cell. Biol. 91, 247–256.
Duhe, R. J., Nielsen, M. D., Dittman, A. H., Villacres, E. C., Choi, E.-J., and Storm, D. R. (1994). J. Biol. Chem. 269, 7290–7298.
Panagiotidis, G., Lindström, P., Stenström, A., and Lundquist, I. (1993). Metabolism 42, 1398–1404.
Henningsson, R., Alm, P., Ekström, P., and Lundquist, I. (1999). Diabetes 48, 66–76.
Åkesson, B. and Lundquist, I. (1999). J. Physiol. 515, 463–473.
Gotoh, M., Maki, T., Kiyoizumi, T., Satomi, S., and Monaco, A. P. (1985). Transplantation 40, 437–438.
Heding, L. A. (1966). In: Labelled proteins in tracer studies. Donato, L., Mihaud, G., and Sirchis, J. (eds.), Euratom: Brussels
Ahrén B. and Lundquist, I. (1982). Diabetologia 22, 258–263.
Panagiotidis, G., Salehi, A., Westermark, P., and Lundquist, I. (1992). Diabetes Res. Clin. Pract. 18, 167–171.
Salehi, A., Mosén, H., and Lundquist, I. (1998). Am. J. Physiol. 274 (Endocrinol. Metab. 37): E459-E468.
Rerup, C. and Lundquist, I. (1966). Acta Endocrinol. 52, 357–367.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Åkesson, B., Lundquist, I. Nitric oxide and hydroperoxide affect islet hormone release and Ca2+ efflux. Endocr 11, 99–107 (1999). https://doi.org/10.1385/ENDO:11:1:99
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:11:1:99